Journal article

Enhancing the hepatitis B care cascade in Australia: A cost-effectiveness model

Yinzong Xiao, Jessica Howell, Caroline van Gemert, Alexander J Thompson, Christopher P Seaman, Karen McCulloch, Nick Scott, Margaret E Hellard

JOURNAL OF VIRAL HEPATITIS | WILEY | Published : 2020

Abstract

If Australia is to successfully eliminate hepatitis B as a public health threat, it will need to enhance the chronic hepatitis B (CHB) care cascade. This study used a Markov model to assess the impact, cost and cost-effectiveness of scaling up CHB diagnosis, linkage to care and treatment to reach national and international elimination targets for hepatitis B in Australia. Compared to continued current trends, the model calculated the difference in care cascade projection, disability-adjusted life years (DALYs), costs and the incremental cost-effectiveness ratio (ICER), of scaling up CHB diagnosis, linkage to care and treatment to reach: (a) Australia's 2022 national targets and (b) the WHO's..

View full abstract